Intensifying Insulin Therapy from Basal Insulin to Biphasic Insulin Aspart (BIAsp 30) Improves Glucose Control and Treatment Satisfaction in Patients with Type 2 Diabetes: South Korea Subgroup of IMPROVE™ Study

被引：0
|
作者：
Kim, Chong Hwa
Jeong, Su Jin
Mok, Ji Oh
Ryu, Ohk Hyun
Lee, Kiyoung
Jeong, In Kyung
Lee, Byung Wan
Kim, Hyun Jin
Lee, Sora
Kim, Sun Woo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A566 / A566
页数：1
相关论文
共 50 条
  • [1] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 Diabetes
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    Aminorroaya, Ashraf
    Aboutorabi, Robabeh
    Niafar, Mitra
    Mohammadi, Mohammad
    Parvaresh, Ehsan
    JOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)
  • [2] Biphasic Insulin Aspart 30 (BIAsp 30) Improves Glycemic Control in Patients with Type 2 Diabetes Regardless of Previous Treatment Regimens: The IMPROVE Study in Iran
    Esteghamati, Alireza
    Rajabian, Reza
    Amini, Masoud
    Bahrami, Amir
    Khamseh, Mohammad Ebrahim
    Ardekani, Mohammad
    Rizi, Ehsan Parvaresh
    DIABETES, 2009, 58 : A516 - A516
  • [3] Improved Safety and Efficacy Profile in Patients with Type 2 Diabetes Treated with Biphasic Insulin Aspart 30 (BIAsp 30): Iran Subgroup of the IMPROVE Study
    Esteghamati, Alireza
    Rajabian, Reza
    Amini, Masoud
    Bahrami, Amir
    Khamseh, Mohammad Ebrahim
    Ardekani, Mohammad Afkhami
    Rizi, Ehsan Parvaresh
    DIABETES, 2009, 58 : A527 - A527
  • [4] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
    Valensi, Paul
    DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
  • [5] Better glycaemic control for 30,171 insulin-naive patients with type 2 diabetes after starting biphasic insulin aspart 30/70 (BIAsp 30) therapy:: IMPROVE™ study subgroup analysis
    Kawamori, R.
    Srishyla, M. V.
    Wenying, Y.
    DIABETOLOGIA, 2008, 51 : S393 - S394
  • [6] Use of a New Basal Insulin with a Bolus Boost (IDegAsp) in Type 2 Diabetes: Comparison with Biphasic Insulin Aspart 30 (BIAsp 30)
    Vaag, Allan
    Leiter, Lawrence A.
    Franek, Edward
    Weng, Jianping
    Damci, Taner
    Munoz Torres, Manuel
    Donnet, Jean-Paul
    Endahl, Lars
    Skjoth, Trine V.
    Niskanen, Leo
    DIABETES, 2011, 60 : A313 - A313
  • [7] Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix®study
    Jang, H. C.
    Lee, S. R.
    Vaz, J. A.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 20 - 26
  • [8] LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS
    Ligthelm, R.
    Christensen, T. E.
    Thomsen, T. L.
    Yang, W.
    VALUE IN HEALTH, 2009, 12 (07) : A402 - A402
  • [9] Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study
    Gumprecht, J.
    Benroubi, M.
    Borzi, V.
    Kawamori, R.
    Shaban, J.
    Shah, S.
    Shestakova, M.
    Wenying, Y.
    Ligthelm, R.
    Valensi, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (06) : 966 - 972
  • [10] COST-EFFECTIVENESS OF INSULIN DEGLUDEC/INSULIN ASPART (IDEGASP) COMPARED WITH BIPHASIC INSULIN ASPART (BIASP 30) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM A MEXICAN HEALTHCARE PERSPECTIVE
    Sanchez-Pedraza, V
    Hansen, B. B.
    Gundgaard, J.
    Uranga Romano, Garca J.
    Evans, M.
    VALUE IN HEALTH, 2016, 19 (07) : A672 - A672
12345